Three new dammarane monodesmosides, named notoginsenosides Ft1 (1), Ft2 (2), and Ft3 (3), together with three known ginsenosides, were obtained from a mild acidic hydrolysis of the saponins from notoginseng (Panax notoginseng (Burk.) F. H. Chen) leaves. Their structures were elucidated to be (3β,12β,20R)-12,20-dihydroxydammar-24-en-3-yl O-β-D-xylopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-(1 → 2)-β-D-glucopyranoside (1), (3β,12β)-12,20,25-trihydroxydammaran-3-yl O-β-D-xylopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-(1 → 2)-β-D-glucopyranoside (2), and (3β,12β,24ξ)-12,20,24-trihydroxydammar-25-en-3-yl O-β-D-xylopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-(1 → 2)-β-D-glucopyranoside (3), by means of spectroscopic evidences. The known ginsenosides Rh2 and Rg3 4–6 were obtained as the major products from this acidic deglycosylation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: